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Introduction
Primary malignant melanoma of the esophagus is 
a rare but aggressive tumor that accounts for <1% of
all esophageal neoplasms.1 Worldwide, approximately
only 250 cases have been published in the English liter-
ature to date,2 however, individual case reports have
been described in the radiology literature.3,4 We report
2 male patients with histopathologically confirmed pri-
mary malignant melanomas of the esophagus and des-
cribe the radiologic findings of barium esophagogram,
coronal reformatted and curved multiplanar reforma-
tion computed tomography (CT).
Case Reports
Case 1
A 77-year-old male had been complaining of dysphagia
for about 2 months. His family history was unremark-
able. No significant pigmented skin lesion and lymph
node swelling were found on physical examination.
Routine blood and urine profiles were also unremark-
able. Endoscopy showed a lobulated mass in the eso-
phagus situated 26 cm from the incisors. CT scan
revealed a bulky, polypoid, intraluminal mass in the
middle and lower third of the esophagus, 8 cm in dia-
meter and extending for 16 cm (Figure 1), and several
small nodules in both lower lungs suggesting meta-
stases. There was no significant lymphadenopathy in
the mediastinum or metastasis in the liver. Endoscopic
biopsy was performed. Histologically, the tumor was
composed of atypical melanocytes in oval-to-spindle
shape and demonstrated great variation in size and
shape. Melanin pigments were present. Immunohis-
tochemistry was positive with antibodies against
HMB-45, and negative with antibodies against cyto-
keratins. Based on histologic and immunohistochemi-
cal studies, the diagnosis of malignant melanoma was
made. Four months later, follow-up CT showed mul-
tiple metastases in the liver and right adrenal gland as
well as supraclavicular and mediastinal lymphadeno-
pathy. The patient refused further treatment and was
discharged.
Case 2
A 62-year-old man presented with a history of dys-
phagia for 1 month and lost approximately 2 kg in
weight since the onset of illness. His past medical his-
tory, family history, routine blood and urine tests were 
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unremarkable. There were no suspicious pigmented
lesions of the skin or eyes on physical examination.
Endoscopic examination disclosed an ulcerated lobu-
lated mass in the esophagus extending 30–43 cm
from the incisors. Double-contrast esophagogram
showed a long, polypoid mass expanding the distal
esophagus without causing obstruction (Figure 2). CT
scan confirmed an eccentric polypoid intraluminal
mass from the middle to lower third of the esophagus
(Figure 3) and enlarged lymph nodes in the media-
stinum; there was no significant metastasis in the 
visceral organs. The endoscopic biopsy specimen
identified the lesion as malignant melanoma. The
patient underwent a transthoracic esophagectomy
with cervical esophagogastric anastomosis. The histo-
logic finding demonstrated the tumor to be com-
posed of round to spindle cells with abundant
melanin pigments. Cellular pleomorphism, prominent
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Figure 1. Primary malignant melanoma of the esophagus in a 77-year-old man with a nasogastric tube inserted (arrow): (A) axial, (B) coro-
nal reformatted, and (C) curved multiplanar reformation contrast-enhanced computed tomography scans revealed a bulky, polypoid and
intraluminal mass in the middle and lower third of the esophagus with compression of adjacent mediastinal structures.
Figure 2. Double-contrast esophagogram in a 62-year-old man with
primary malignant melanoma of the esophagus showed a long,
polypoid mass expanding the distal esophagus without causing
obstruction.
Figure 3. Contrast-enhanced computed tomography scan in a 62-
year-old man with primary malignant melanoma of the esophagus
demonstrated an eccentric polypoid intraluminal mass in the lower
third of the esophagus.
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nucleoli, and numerous mitotic figures were encoun-
tered. The tumor cells were positive for HMB-45 and
negative for cytokeratins by immunohistochemical
analysis. Two months later, follow-up CT revealed
masses in the right adrenal gland and lower pole of
the right kidney. Right radical nephrectomy was 
performed and metastases were proved. The post-
operative course was uneventful and this patient is
doing well.
Discussion
Primary malignant melanoma most commonly origi-
nates from the skin; other less common extracutaneous
locations include squamous mucous membranes, uvea,
retina, leptomeninges, genitourinary tract, digestive
tract, biliary tract, and upper respiratory tract.5 The
vulva and urethra are the most common sites of origin
of malignant melanomas in the genitourinary tract. Pri-
mary melanoma of the gastrointestinal tract is exceed-
ingly rare, conversely, cutaneous melanoma is the most
common malignancy to metastasize to the gastroin-
testinal tract. In 1 series, the small intestine (75%),
large bowel (25%), and stomach (16%) were common
sites for metastases; the small intestine was the most
frequent site of metastatic melanoma because of its rich
blood supply.6 Metastasis to the esophagus is extremely
rare. It reportedly occurs in only 4% of patients who die
of metastatic melanoma at autopsy.7 Classically, meta-
static melanoma to the stomach and duodenum appears
as a polypoid mass with or without central ulceration,
the so-called “Bull’s-eye” lesion.8
Primary malignant melanoma of the esophagus is 
a rare condition and has a reported prevalence of 
0.1–0.5% of all esophageal malignancies.1 It is generally
considered that primary melanoma could not develop in
the esophagus because of the lack of precursor cells, until
De La Pava et al9 in 1963 demonstrated the presence of
typical melanocytes in the esophageal mucosa in 4%
of normal esophagi at autopsy. This finding clarified
definitively that malignant melanoma can occur as a pri-
mary tumor from the esophageal mucosa. It is twice as
common in males as in females, occurring prevalently in
the 6th and 7th decades of life. This malignancy is most
commonly located in the middle or distal third of the
esophagus, approximately in 90% of cases, probably
because of the greater concentration of melanocytes in
these regions.2,10
The diagnostic criteria for accepting a melanoma
as arising from the esophagus were defined by Allen
and Spitz,11 and require the presence of melanin gran-
ules within the tumor cells as well as melanocytes in the
overlying epithelial layer and areas of junctional activity
within squamous mucosa and the adjacent epithelium.
The more accurate diagnosis is confirmed by immuno-
histochemical studies: primary malignant melanoma
of the esophagus typically reveals a positive antibody-
specific cytoplasmic reactivity to HMB-45 and S-100
proteins with a negative reaction for cytokeratin or
CEA.10 Ruling out a metastatic lesion is important if
melanoma is found in the esophagus. Consequently,
the diagnosis of primary esophageal melanoma can be
accepted only in patients with no history of melanoma
and no evidence at physical examination of melanoma
involving the skin, eye, anus, or vagina.
There is no significant risk factor of primary malig-
nant melanoma of the esophagus. The most common
symptoms are dysphagia, substernal or epigastric pain,
hematemesis, and melena. Physical signs other than
weight loss are uncommon. On endoscopy, these
tumors usually appear as lobulated and darkly colored
masses with intact mucosa or occasional ulceration.10
However, data obtained from specimens after endo-
scopic biopsy are limited for a definitive diagnosis and
occasionally misdiagnosed as poorly differentiated 
carcinoma. The histopathologic diagnosis is usually
confirmed after en bloc resection.12
Barium esophagography usually reveals a bulky,
polypoid intraluminal mass focally expanding the
esophagus. A considerable degree of obstruction is
uncommon. CT of the thorax reveals a bulky esopha-
geal mass compressing the adjacent mediastinal struc-
tures. Approximately 40.9% of patients are reported
to have metastases at the time of diagnosis. The most
commonly involved sites are the paraesophageal
lymph nodes (10.8%), supraclavicular lymph nodes
(7%), liver (7%), lungs (6%), celiac lymph nodes (4%),
and bones (2.9%).13 CT might be useful in demon-
strating mediastinal invasion, nodal enlargement, and
distant metastatic disease. Magnetic resonance imag-
ing shows high signal intensity masses in the esopha-
gus on T1-weighted imaging due to paramagnetic
scavenging by melanin, which helps preoperative
diagnosis.
The differential diagnosis of primary esophageal
melanoma includes spindle cell carcinoma, leiomyo-
sarcoma, and Kaposi’s sarcoma. A large lobulated
intraluminal lesion that expands the lumen without
causing obstruction is the characteristic findings of
barium study for spindle cell carcinoma. The manifes-
tation of leiomyosarcoma is a heterogeneous, large,
and exophytic mass with central areas of necrosis on
CT scan. Kaposi’s sarcomas typically appear as multi-
ple submucosal masses or polypoid lesions in the
esophagus. These tumors are difficult to differentiate
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from malignant melanoma on the basis of radiographic
criteria.
The prognosis of primary malignant melanoma 
of the esophagus is dismal regardless of therapy in
comparison with other common primary malignant
tumors of the esophagus. The average overall survival
is only 10–13 months, with the 5-year survival rate
ranging from 0% to 4%.13 Metastases are present at
the time of diagnosis in 40.9% of cases. Approximately
85% of patients progress to early death with dissemi-
nated disease. The most common sites involved at
autopsy are the liver (39.3%), mediastinum (34.4%),
lungs (24.6%), pleura (19.7%), supraclavicular lymph
nodes (19.7%), peritoneum (14.8%), brain (13.1%),
kidneys and adrenals (11.5%).13
The treatment preferred for primary malignant
melanoma of the esophagus is surgical resection. A
total or near-total esophagectomy is mandatory as 
the tumor spreads longitudinally. Currently, radio-
therapy, chemotherapy, and immunotherapy have not
proved beneficial. However, these alternative thera-
peutic modalities play a palliative role if surgery is not
possible.2,10
In conclusion, primary malignant melanomas of
the esophagus are rare, aggressive tumors with fatal
prognosis and should be considered in the differential
diagnosis of bulky, polypoid masses that expand the
esophagus on esophagograms and chest CT scan.
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